NurExone Biologic Inc. (TSXV:NRX)
Canada
· Delayed Price · Currency is CAD 0.6700
-0.0200 (-2.90%)
Jun 20, 2025, 4:00 PM EDT
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 53.61 million as of June 20, 2025. Its market cap has increased by 66.18% in one year.
Market Cap
53.61M
Enterprise Value
52.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 53.61M, an increase of 60.10%. That is a compound annual growth rate of 17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 53.61M | 21.96% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sienna Senior Living | 1.71B |
| dentalcorp Holdings | 1.63B |
| Green Thumb Industries | 1.62B |
| Extendicare | 1.18B |
| Cronos Group | 998.24M |
| WELL Health Technologies | 977.53M |
| Trulieve Cannabis | 940.21M |
| Curaleaf Holdings | 870.97M |